Search Results

Butterfly Network, Inc. today announced that Joseph DeVivo, President, Chief Executive Officer and Chairman will present and host one-on-one investor meetings at the Goldman Sachs 45th Annual Global Healthcare Conference.

Butterfly Network, Inc. today announced the FDA clearance of its next-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3.

Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with handheld, whole-body ultrasound, today announced financial results for the quarter ended June 30, 2023, and provided a business update.

Butterfly Network, Inc. announced that it will report first quarter 2023 financial results and provide a business update on May 11, 2023, before the market opens.

Butterfly Network, Inc. announced today that it has received 510(k) clearance for a groundbreaking AI-enabled Auto B-line Counter that may simplify how healthcare professionals evaluate adults with suspected diminished lung function and can potentially accelerate their ability to make informed treatment decisions at the point of care.

Butterfly Network, Inc. announced that it will report third quarter 2022 financial results and provide a business update on November 3, 2022, before the market opens.

Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ultrasound, announced financial results for the quarter ended June 30, 2022, and provided a business update.

Genialis, the RNA-biomarker company, announced a new partnership with the Pancreatic Cancer Action Network to expand the validation of the Genialis™ krasID biomarker in the pancreatic cancer histology.